OFS
CNTA

OneAscent Financial Services’s Centessa Pharmaceuticals CNTA Stock Holding History

OneAscent Financial Services’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,324
Closed -$162K – 413
2025
Q2 		$162K Sell
12,324
-892
-7% -$11.3K 0.01% 517
2025
Q1 		$190K Buy
+13,216
New +$216K 0.01% 480

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

OneAscent Financial Services's CNTA Position: Q3 2025 in Review

OneAscent Financial Services sold out of Centessa Pharmaceuticals (CNTA) in Q3 2025, closing a stake of 12,324 shares — an estimated $162K sold.

OneAscent Financial Services first reported a position in CNTA in Q1 2025 and held it in 2 quarters. The position peaked at $190K in Q1 2025. 125 funds tracked by Wall St. Rank hold CNTA as of Q3 2025.

  • OneAscent Financial Services reported no remaining Centessa Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • OneAscent Financial Services sold 12,324 Centessa Pharmaceuticals shares in Q3 2025, an estimated $162K.
  • OneAscent Financial Services first reported a position in Centessa Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • OneAscent Financial Services's Centessa Pharmaceuticals position peaked at $190K in Q1 2025.
  • 125 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q3 2025.

Based on OneAscent Financial Services's 13F filing for Q3 2025, filed 22 Oct 2025.